title: Approaches to the design of anti-fibrotic drugs.
authors.affiliation: Research I, ICI Pharmaceuticals, Macclesfield, Cheshire, U.K.
authors.forename: T J
authors.initials: TJ
authors.lastname: Franklin
authors.forename: N J
authors.initials: NJ
authors.lastname: Hales
authors.forename: D
authors.initials: D
authors.lastname: Johnstone
authors.forename: W B
authors.initials: WB
authors.lastname: Morris
authors.forename: C J
authors.initials: CJ
authors.lastname: Cunliffe
authors.forename: A J
authors.initials: AJ
authors.lastname: Millest
authors.forename: G B
authors.initials: GB
authors.lastname: Hill
mesh_terms: D000600:Amino Acids, Dicarboxylic / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D003094:Collagen / Q000378:metabolism; D015195:Drug Design; D005355:Fibrosis / Q000188:drug therapy*; D006801:Humans; D006900:Hydroxylation; D011393:Procollagen-Proline Dioxygenase / Q000037:antagonists & inhibitors
chemical_list: D000600:Amino Acids, Dicarboxylic; D003094:Collagen; D011393:Procollagen-Proline Dioxygenase; C040947:oxalylglycine